Approved
consistent with the understanding that NIH will submit a full
package for the larger ongoing study within three months.
Inventory as of this Action
Requested
Previously Approved
10/31/2015
6 Months From Approved
600
0
0
1,500
0
0
0
0
0
The collection of the information
required for the study "Human Influenza Surveillance of Health Care
Centers in the United States and Taiwan" directly ties to the core
mission of NIAID and NIH. The surveillance that will be conducted
under this protocol (Attachment 2) will permit timely
identification of Influenza viruses with pandemic potential, as
well as variant seasonal influenza virus strains such as those
resulting from antigenic drift; complementary clinical research
will assess serologic and immunologic correlates of infection and
disease severity. The sites that will be developed in the US and
Taiwan will provide the US government with capacities to respond
appropriately to emerging and re-emerging influenza strains. This
study will provide information to better understand influenza in
the human population in close to real time by utilizing advanced
molecular testing methods which permit triaging (or selection) of
sample for more in-depth analysis. The knowledge gained will be
utilized to enhance health and reduce illness due to influenza
infection.
This is a request for an
emergency clearance of the “Human Influenza Surveillance of Health
Care Centers in the United States and Taiwan Study” on the grounds
that this is essential to the mission of The National Institute of
Allergy and Infectious Diseases (NIAID) and that NIAID cannot
reasonably comply with the normal clearance procedures and this
would likely prevent or substantially disrupt the collection of
information (5CFR 1320.13, see Attachment 1- Memo requesting
Emergency Exemption). In addition, prevention of the study would
cause public harm through the loss of critically needed information
to understand the nature of the virus strains causing influenza
during this year of increased influenza activity. The information
gathered is critical for public health preparedness measures for
the next influenza season, because characterizing current influenza
virus strains effects the choice of next year’s influenza vaccine
strains and helps determine effective treatment strategies by
assessing the degree of antiviral resistance present in current
influenza virus strains.
US Code:
42
USC 285f Name of Law: Public Health Service Act
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.